We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

African Pharmaceutical Market Analysis By Therapeutic Class , By Drug Categories, By Inhalants, By Anabolic Steroids & by RegionWith COVID-19 impact | Forecast Period 2019-2035

Published Date :

2021-05-18

Report Pages :

810

Format :

PDF/PPT/XLS/Hard Copy

Region Covered :

Africa

African Pharmaceutical Market Outlook

Africa is the only pharmaceutical market where genuinely high growth is still achievable, value of Africa’s pharmaceutical industry jumped to USD 28.56 billion in 2017 from just USD 5.5 billion a decade earlier. That growth is continuing at a rapid pace: we predict the market will be worth USD 56 billion to USD 70 billion by 2030. It is opportunistic for multinationals and pharmaceutical companies seeking new sources of growth as developed markets stagnate while patients will also gain access to medicines previously unavailable on the continent.

Africa Pharmaceutical Market Segmentation

On the Basis of Therapeutic Class

  • Oncology
  • Central Nervous System
  • Reproductive Medicine & Women’s Health
  • Cardiovascular
  • Metabolic
  • Orhthopaedics
  • Endocrine
  • Antiviral
  • Diabetes
  • Antibiotic
  • Gastrointestinal
  • Genitourinary
  • Respiratory
  • Ophthalmic
  • Antifungal
  • Musculoskeletal
  • Hematology
  • Radiology
  • Dermatology
  • Phototherapy
  • Antihelminthic

On the Basis of Drug Categories

  • Stimulants

Cocaine

Methamphetamines

Amphetamines

Ritalin

Cylert

  • Inhalants

Glues

Paint thinner

Gasoline

Laughing gas

Aerosol sprays

  • Cannabinoids

Hashish

Marijuana

  • Depressants

Barbiturates

Benzodiazepines

Flunitrazepam

GHB (Gamma-hydroxybutyrate)

Methaqualone

Alcohol

Tranquillisers

  • Opioids & Morphine Derivatives

Codeine

Fentanyl and fentanyl analogs

Heroin

Morphine

Opium

Oxycodone HCL

Hydrocodone bitartrate, acetaminophen

  • Anabolic Steroids

Anadrol

Oxandrin

Durabolin

Stanozol

Dianabol

  • Hallucinogens

LSD (lysergic acid diethylamide)

Mescaline

Psilocybin

Magic Mushrooms

  • Prescription Drugs

Opiods: Codeine, Oxycodone, Morphine

Central nervous system depressants: barbiturates, benzodiazepines

Stimulants: dextroamphetamine, methylphenidate

On the Basis of Distribution Channel

  • Pharmacy/OTC Stores
  • Retail Stores
  • Online Channel

On the Basis of Countries

  • South Africa Pharmaceutical Market
  • Nigeria Pharmaceutical Market
  • Morocco Pharmaceutical Market
  • Kenya Pharmaceutical Market
  • Ghana Pharmaceutical Market
  • Algeria Pharmaceutical Market
  • Tunisia Pharmaceutical Market
  • Tanzania Pharmaceutical Market
  • Sudan Pharmaceutical Market
  • Rest of Africa Pharmaceutical Market

Market Dynamics

Africa’s pharmaceutical markets are growing in every segment, given that between 2017 and 2030, prescription drugs are forecast to grow at a compound annual growth rate of 6.5%, generics at 10%, over-the-counter medicines at 7.1%, and medical devices at 12.1%. Increasing urbanisation, healthcare capacity and supportive business environment are the drivers of the Africa pharmaceutical market. For early movers in order to pursue competitive advantage requires focus on pockets of growth like much of the opportunity lies not at country level, but in cities. According to the analysis, 37% of African consumers are concerted in 30 cities, which will have more consuming households than Australia and the Netherlands combined by 2025. Addressing supply and distribution challenges, building stronger team and forging partnerships are the “to win strategies” as global pharmaceutical companies need local business partners like manufacturers, packaging companies, and distributor in order to help them navigate the continent’s many markets, with their widely varying consumer preferences, price points, manufacturing, and distribution infrastructures.

The market research report titled “Africa Pharmaceuticals Market” by Goldstein Market Intelligence is the comprehensive review of market drivers, trends, opportunities, issues and restraints in addition to This report analyses the Africa markets for pharmaceuticals in USD Million. The report provides separate comprehensive analytics for the South Africa, Tanzania, Algeria, Sudan, Kenya, Morocco, Ghana and Tunisia pharmaceuticals market. The country analysis provides insights about the target and potential markets for pharmaceuticals across the Africa continent.

Covered in this African Pharmaceutical Market report

The market study includes annual estimates and forecast data on the basis of historical market analysis (2016-2017), current market analysis (2018) & forecast analysis (2019-2030) are derived from primary and secondary research. The research reports covers the Trade Data (Export & Import), By value & volume, Sales (in USD), Investment Flow Analysis, Pipeline Products Insights, Competitive Analysis of Players which includes mergers & acquisition activities, financial analysis, Start-ups associated, global presence, patents, product portfolio, brand recognition & market competition.

COVID-19 impact on "African Pharmaceutical Market"

Impact of COVID-19 Outbreak on African Pharmaceutical Industry, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Nigerian Pharma Industry. It also showcases the expected recovery schedule and losses in the industry and other various major factors. 

Market Share by Key Players 

Market Players

Market Share (%)

Adcock Ingram

12.1%

Novartis

11.5%

Merck & Co.

9.7%

Johnson & Johnson

8.8%

Pfizer

8.8%

Sanofi

7.4%

Bayer

7.1%

Roche

6.9%

Aspen

5.21%

Cipla

5.0%

Market Study Pattern

Product Analysis

  • Usage pattern (in-depth trend analysis) of pharmaceuticals market (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • Applications of the pharmaceuticals market products (segment and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

Epidemiology Data

  • Country-specific presence of target audience that include research organizations, pharmacies, drug manufacturers and the other major end users.

Manufacturer Analysis

  • Fast turn-around analysis of user response to market events and trends
  • Pattern analysis of usage of pharmaceuticals products by users involved

Brand/Product Perception Matrix

  • Comprehensive study of end user perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Alternative Products: Impact analysis

It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (Patient pool, epidemiology of disease, preference towards OTC’s) and Macroeconomic indicators (investment rate and FDA regulations).

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Primary Survey Breakdown

For a detailed overview, send here request for market report sample.




{ }

African Pharmaceutical Market Analysis By Therapeutic Class , By Drug Categories, By Inhalants, By Anabolic Steroids & by RegionWith COVID-19 impact | Forecast Period 2019-2035

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type